Doceree Closes $11 Mn Series A Funding Round Led by Eight Roads Ventures And Others

• ByStartupStory     |    April 7, 2022

Doceree Inc, the world’s first worldwide network of physician-only platforms for programmatic messaging, has raised $11 million in a Series A round headed by Eight Roads Ventures, a global investment firm supported by Fidelity. The round was also attended by F-Prime Capital and Alkemi Growth Capital.

Doceree plans to use the cash to expand its global operations, expand alliances, extend its product offering, and improve the platform’s measurement and behavior lift capabilities in order to improve transparency. The investment will also help it strengthen communications with healthcare professionals (HCPs) for pharma and life sciences companies, agencies, and health information technology platforms.

Doceree’s industry-first solutions, which are powered by ESPYIANTM, Doceree’s proprietary identity-resolution technology, enable messaging and targeting of HCPs on endemic (sites physicians visit for knowledge, professional development, or to connect with their peer group) and point-of-care (platforms where physicians tend to their patients) platforms. In a fast-evolving digital pharma marketing ecosystem, the platform improves engagement between life sciences organizations and their target audience through its global publisher network.

Doceree, a life sciences brand and media agency founded in 2019 by Harshit, a former physician who transitioned into the healthcare marketing space, empowers life sciences brands and media agencies with solutions that seamlessly reach HCPs on professional HCP networks and within their digital workflow to improve patient health outcomes. Through its programmatic messaging capabilities, the company has optimized HCP communications to assist advertisers in creating more efficient, successful, and transparent messaging campaigns.

Doceree Perform, the company’s newest offering, gives life sciences organizations in the United States outstanding measurement capabilities for evaluating campaign effectiveness and improving script lift with data-driven communications. ESPYIANTM allows marketers to target HCPs at a speciality level in India, the United Kingdom, and the European Union, allowing pharma companies to reach them at scale depending on their area of expertise. The company plans to roll out behavioral lift measurement services around the world.

Follow Startup Story